1. Home
  2. PMCB vs AWX Comparison

PMCB vs AWX Comparison

Compare PMCB & AWX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMCB
  • AWX
  • Stock Information
  • Founded
  • PMCB 1996
  • AWX 1998
  • Country
  • PMCB United States
  • AWX United States
  • Employees
  • PMCB N/A
  • AWX N/A
  • Industry
  • PMCB Biotechnology: Biological Products (No Diagnostic Substances)
  • AWX Environmental Services
  • Sector
  • PMCB Health Care
  • AWX Utilities
  • Exchange
  • PMCB Nasdaq
  • AWX Nasdaq
  • Market Cap
  • PMCB 11.4M
  • AWX 13.6M
  • IPO Year
  • PMCB N/A
  • AWX 1998
  • Fundamental
  • Price
  • PMCB $1.78
  • AWX $3.11
  • Analyst Decision
  • PMCB
  • AWX
  • Analyst Count
  • PMCB 0
  • AWX 0
  • Target Price
  • PMCB N/A
  • AWX N/A
  • AVG Volume (30 Days)
  • PMCB 27.8K
  • AWX 14.2K
  • Earning Date
  • PMCB 03-17-2025
  • AWX 03-20-2025
  • Dividend Yield
  • PMCB N/A
  • AWX N/A
  • EPS Growth
  • PMCB N/A
  • AWX N/A
  • EPS
  • PMCB 0.74
  • AWX 0.25
  • Revenue
  • PMCB N/A
  • AWX $83,487,000.00
  • Revenue This Year
  • PMCB N/A
  • AWX N/A
  • Revenue Next Year
  • PMCB N/A
  • AWX N/A
  • P/E Ratio
  • PMCB $2.40
  • AWX $12.32
  • Revenue Growth
  • PMCB N/A
  • AWX N/A
  • 52 Week Low
  • PMCB $1.39
  • AWX $2.00
  • 52 Week High
  • PMCB $2.58
  • AWX $3.99
  • Technical
  • Relative Strength Index (RSI)
  • PMCB 56.75
  • AWX 41.75
  • Support Level
  • PMCB $1.57
  • AWX $3.20
  • Resistance Level
  • PMCB $1.80
  • AWX $3.42
  • Average True Range (ATR)
  • PMCB 0.13
  • AWX 0.19
  • MACD
  • PMCB 0.01
  • AWX -0.02
  • Stochastic Oscillator
  • PMCB 64.10
  • AWX 15.28

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

About AWX Avalon Holdings Corporation

Avalon Holdings Corp is a waste management company. The company provides waste management services to industrial, commercial, municipal, and governmental customers in selected northeastern and midwestern U.S. markets. The company has two operating segments. The Waste management services segment which is the key revenue driver, includes waste disposal services, captive landfill operations, and saltwater injection well operations. Its Golf and related operations segment includes management of golf courses and related clubhouses, a hotel, fitness centers, tennis courts, salon and spa services, dining, banquet, and conference facilities.

Share on Social Networks: